Melphalan Hydrochloride
Who holds supplier records for Melphalan Hydrochloride? 10 organisations hold a current record for Melphalan Hydrochloride: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (5), Italy (3), France (1) and United States (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Melphalan Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/melphalan-hydrochloride
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Melphalan Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 37179 · latest filing Jun 2022
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 27485 · latest filing Sept 2013
- CHEMWERTH INCFranceActive DMF 25644 · latest filing Dec 2011
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 25040 · latest filing Jul 2011
- Farmabios S.p.A.Italy Company GMP cert on recordActive DMF 25791 · latest filing Feb 2012
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 29537 · latest filing Jul 2015
- NAVINTA LLCUnited StatesActive DMF 29766 · latest filing Sept 2015
- NERPHARMA SRLItaly Company GMP cert on recordActive DMF 27306 · latest filing Jul 2013
- OLON SPAItaly Company GMP cert on recordActive DMF 20883 · latest filing Sept 2007
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 28930 · latest filing Jan 2015
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Melphalan Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- India · Inactive DMF 36096 · filed Jul 2021
- China · Inactive DMF 23667 · filed Apr 2010
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Melphalan Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200863).
Chemical identity
- IUPAC name
- (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;hydrochloride
- Canonical SMILES
- C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl.Cl
- InChIKey
- OUUYBRCCFUEMLH-YDALLXLXSA-N
- Synonyms
- Alkeran, Alkeran hydrochloride, CB 3025 HYDROCHLORIDE, CB-3025 HYDROCHLORIDE, Evomela, Hepzato, Ivra, Melphalan hcl, Melphalan hydrochloride, Phelinun, Sarcolysin hydrochloride, l-, Phenylalanine mustard hydrochloride
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Alkylating Drug
- Mechanism of action
- Alkylating Activity
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Melphalan Hydrochloride?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Melphalan Hydrochloride: APITORIA PHARMA PRIVATE LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHEMWERTH INC (France), Emcure Pharmaceuticals Limited (India), Farmabios S.p.A. (Italy), Hetero Labs Limited (India), NAVINTA LLC (United States) and NERPHARMA SRL (Italy), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Melphalan Hydrochloride Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 37179), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 27485), CHEMWERTH INC (DMF 25644), Emcure Pharmaceuticals Limited (DMF 25040), Farmabios S.p.A. (DMF 25791), Hetero Labs Limited (DMF 29537), NAVINTA LLC (DMF 29766) and NERPHARMA SRL (DMF 27306) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Melphalan Hydrochloride records mean?
2 organisations have only inactive Type II DMFs for Melphalan Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Melphalan Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Melphalan Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.